A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer
Clinical trial NCT07123441 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07123441
- Sponsor
- Sanjun Cai
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.